Evidence map›Paper›PMID 36419950›Full record

ArticleInternational journal of chronic obstructive pulmonary disease2022

A Telemedicine Approach for Monitoring COPD: A Prospective Feasibility and Acceptability Cohort Study.

Masahiro Shinoda, Osamu Hataji, Motohiko Miura, Masaharu Kinoshita, Akira Mizoo, Kazunori Tobino, Toru Soutome, Takanobu Nishi, Takeo Ishii, Bruce E Miller and 5 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in International journal of chronic obstructive pulmonary disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 1 country.

Masahiro ShinodaDepartment of Respiratory Medicine, Tokyo Shinagawa Hospital, Shinagawa, Tokyo, Japan.ORCID 0000-0002-0288-5637
Osamu HatajiRespiratory Center, Matsusaka Municipal Hospital, Matsusaka, Mie, Japan.ORCID 0000-0002-1946-2585
Motohiko MiuraDepartment of Respiratory Medicine, Tohoku Rosai Hospital, Sendai, Miyagi, Japan.
Masaharu KinoshitaDepartment of Respiratory Medicine, Nagata Hospital, Yanagawa, Fukuoka, Japan.
Akira MizooDepartment of Pulmonary Medicine Japan, Japan Community Healthcare Organization Tokyo Shinjuku Medical Center, Shinjuku, Tokyo, Japan.
Kazunori TobinoDepartment of Respiratory Medicine, Iizuka Hospital, Iizuka, Fukuoka, Japan.
Toru SoutomeJapan Medical & Development, GSK K.K, Minato-Ku, Tokyo, Japan.
Takanobu NishiJapan Medical & Development, GSK K.K, Minato-Ku, Tokyo, Japan.ORCID 0000-0003-2272-6833
Takeo IshiiJapan Medical & Development, GSK K.K, Minato-Ku, Tokyo, Japan.ORCID 0000-0001-6865-1967
Bruce E MillerGSK Pharma R&D, Collegeville, PA, USA.ORCID 0000-0003-3904-3182
Ruth Tal-SingerGSK Pharma R&D, Collegeville, PA, USA.ORCID 0000-0002-5275-8062
Ryan TomlinsonGSK Pharma R&D, Collegeville, PA, USA.ORCID 0000-0002-7875-7607
Taizo MatsukiJapan Medical & Development, GSK K.K, Minato-Ku, Tokyo, Japan.ORCID 0000-0002-0591-4261
Paul W JonesGeneral Medicine, GSK, Brentford, Middlesex, UK.ORCID 0000-0001-6087-9182
Yoko ShibataDepartment of Pulmonary Medicine, Fukushima Medical University, Fukushima, Japan.ORCID 0000-0003-1794-0026
MSD K.K. (Japan) · JPAso Iizuka Hospital · JPFukushima Medical University · JPJapan Community Healthcare Organization · JPNew Tokyo Hospital · JPSoka Municipal Hospital · JPTohoku Rosai Hospital · JPYanagawa Rehabilitation Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Telemedicine may help the detection of symptom worsening in patients with chronic obstructive pulmonary disease (COPD), potentially resulting in improved outcomes. This study aimed to determine the feasibility and acceptability of telemedicine among patients with COPD and physicians and facility staff in Japan. Methods: This was a 52-week multicenter, prospective, single-arm, feasibility and acceptability cohort study of Japanese patients ≥40 years of age with COPD or asthma-COPD overlap. Participants underwent training to use YaDoc, a telemedicine smartphone App, which included seven daily symptom questions and weekly COPD Assessment Test (CAT) questions. The primary endpoint was participant compliance for required question completion. The secondary endpoint was participant and physician/facility staff acceptability of YaDoc based on questionnaires completed at Week 52. The impact of the Japanese COVID-19 pandemic state of emergency on results was also assessed. Results: Of the 84 participants enrolled (mean age: 68.7 years, 88% male), 72 participants completed the study. Completion was high in the first six months but fell after that. Median (interquartile range [IQR]) compliance for daily questionnaire entry was 66.6% (31.0-91.8) and 81.0% (45.3-94.3) for weekly CAT entry. Positive participant responses to the exit questionnaire were highest regarding YaDoc ease of use (83.8%), positive impact on managing health (58.8%), and overall satisfaction (53.8%). Of the 26 physicians and facility staff enrolled, 24 completed the study. Of these, the majority (66.7%) responded positively regarding app facilitation of communication between physicians and participants to manage disease. Compliance was similar before and after the first COVID-19 state of emergency in Japan. Conclusion: Daily telemedicine monitoring is potentially feasible and acceptable to both patients and physicians in the management of COPD. These results may inform potential use of telemedicine in clinical practice and design of future studies. Clinical Trial Registration: JapicCTI-194916.

Indexed as

COVID-19Pulmonary Disease, Chronic ObstructiveTelemedicineCohort StudiesFeasibility StudiesFemaleHumansMalePandemicsProspective StudiesacceptabilityfeasibilityJapanpatient-reported outcome measuresmartphonetelemonitoring

Identifiers

PMID36419950
PMCPMC9677662
OpenAlexW4309320751

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.